| Financial Year |
March 31 2023 |
| Monetary Funds |
456,765,869.65 |
| Held-for-trading Financial Assets |
168,000,000.00 |
| Notes Receivable |
15,579,410.97 |
| Accounts Receivable |
579,348,475.77 |
| Advances to Suppliers |
21,140,713.12 |
| Other Receivables |
12,159,554.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
288,791,898.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
65,094.79 |
| Other Current Assets |
18,918,506.84 |
| Total Current Assets |
1,679,852,389.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
77,882,851.35 |
| Fixed Assetes |
215,675,263.04 |
| Under-construction Projects |
32,918,922.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
157,290,570.33 |
| R&D expenses |
-- |
| Goodwill |
4,529,055.50 |
| Long-Term Deferred and Prepaid Expenses |
9,557,425.51 |
| Deferred Income Tax Assets |
20,867,261.15 |
| Other Non-Current Assets |
6,545,830.67 |
| Sub-Total of Non-Current Assets |
532,601,427.31 |
| Total Assets |
2,212,453,817.15 |
| Short-Term Loans |
165,118,888.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
90,008,531.32 |
| Accounts Payable |
315,134,096.69 |
| Accounts Received In Advance |
1,521,920.45 |
| Employee Compensation Payable |
12,772,718.31 |
| Taxes Payable |
9,915,894.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,987,542.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
5,763,985.25 |
| Sub-Total of Current Liabilities |
656,261,157.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,278,339.17 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,688,439.06 |
| Total Liabilities |
666,949,596.87 |
| Paid-In Capital(Or Share Stock) |
362,079,880.00 |
| Capital Surplus |
517,375,855.40 |
| Surplus Reserve |
80,567,784.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
540,455,365.47 |
| Minority Stockholder's Interest |
45,025,334.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,500,478,885.42 |
| Owner's Equity（Stockholder's Equity） |
1,545,504,220.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,212,453,817.15 |
